Page results
-
Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
UCH Chemotherapy Daycare and the Macmillan Support and Information Service are shortlisted for a Patient Experience Network National Award for the use of data from the Cancer Patient Experience Survey to improve patient experience.
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
-
The video-assisted stroke triage project, developed by the UCLH stroke service in partnership London Ambulance Service (LAS) has won the HSJ Patient Safety Award for Clinical Governance & Risk Management in Patient Safety.
-
This page provides information for patients who are due to be admitted to hospital for bowel surgery.
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
-
As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.
-
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
-
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
File results
-
FOI/2023/0591 - Healthcare Assistants agency rates 2023
-
FOI/2023/0592 - Procurement staff organisation chart
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0532 - Patient treatment/ care/ consent